
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
Shanshan Wang, Mingyue Zhu, Qiaoyun Wang, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 10
Open Access | Times Cited: 100
Shanshan Wang, Mingyue Zhu, Qiaoyun Wang, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 10
Open Access | Times Cited: 100
Showing 1-25 of 100 citing articles:
Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma
Yifei Zheng, Mingyue Zhu, Mengsen Li
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 10, pp. 2439-2446
Closed Access | Times Cited: 141
Yifei Zheng, Mingyue Zhu, Mengsen Li
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 10, pp. 2439-2446
Closed Access | Times Cited: 141
IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
Junnv Xu, Haifeng Lin, Gang Wu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 139
Junnv Xu, Haifeng Lin, Gang Wu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 139
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 85
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 85
SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway
Mao Zhang, Shihai Liu, Mei‐Sze Chua, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 8
Open Access | Times Cited: 110
Mao Zhang, Shihai Liu, Mei‐Sze Chua, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 8
Open Access | Times Cited: 110
Stigmasterol Simultaneously Induces Apoptosis and Protective Autophagy by Inhibiting Akt/mTOR Pathway in Gastric Cancer Cells
Huange Zhao, Xian Zhang, Min Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 82
Huange Zhao, Xian Zhang, Min Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 82
Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression
Zexia Wang, Fei Liu, Wenli Liao, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 689, pp. 108412-108412
Closed Access | Times Cited: 81
Zexia Wang, Fei Liu, Wenli Liao, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 689, pp. 108412-108412
Closed Access | Times Cited: 81
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
Ralf Weiskirchen, Frank Tacke
Cells (2019) Vol. 8, Iss. 1, pp. 16-16
Open Access | Times Cited: 77
Ralf Weiskirchen, Frank Tacke
Cells (2019) Vol. 8, Iss. 1, pp. 16-16
Open Access | Times Cited: 77
The Role of Alpha-Fetoprotein (AFP) in Contemporary Oncology: The Path from a Diagnostic Biomarker to an Anticancer Drug
Joanna Głowska-Ciemny, Marcin Szymański, Agata Kuszerska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2539-2539
Open Access | Times Cited: 33
Joanna Głowska-Ciemny, Marcin Szymański, Agata Kuszerska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2539-2539
Open Access | Times Cited: 33
Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells
Minni Zhang, Kun Liu, Qiuyue Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Minni Zhang, Kun Liu, Qiuyue Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway
Yan Yu, Dan Zhao, Kongfei Li, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 56
Yan Yu, Dan Zhao, Kongfei Li, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 56
Autophagy, an accomplice or antagonist of drug resistance in HCC?
Yafei Wu, Jigang Zhang, Qin Li
Cell Death and Disease (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 51
Yafei Wu, Jigang Zhang, Qin Li
Cell Death and Disease (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 51
The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer
Anam Al Arif, Ameer A. Alameri, Umer Bin Tariq, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109581-109581
Closed Access | Times Cited: 36
Anam Al Arif, Ameer A. Alameri, Umer Bin Tariq, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109581-109581
Closed Access | Times Cited: 36
Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosis
Samaneh Siapoush, Ramazan Rezaei, Helia Alavifard, et al.
Life Sciences (2023) Vol. 329, pp. 121894-121894
Closed Access | Times Cited: 19
Samaneh Siapoush, Ramazan Rezaei, Helia Alavifard, et al.
Life Sciences (2023) Vol. 329, pp. 121894-121894
Closed Access | Times Cited: 19
New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies.
Shuo Yang, Liang Yang, Xinyu Li, et al.
PubMed (2019) Vol. 9, Iss. 7, pp. 1329-1353
Closed Access | Times Cited: 53
Shuo Yang, Liang Yang, Xinyu Li, et al.
PubMed (2019) Vol. 9, Iss. 7, pp. 1329-1353
Closed Access | Times Cited: 53
Anemoside B4 exerts anti-cancer effect by inducing apoptosis and autophagy through inhibiton of PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
Shuyi Xue, Yu Zhou, Jin Zhang, et al.
PubMed (2019) Vol. 11, Iss. 4, pp. 2580-2589
Closed Access | Times Cited: 52
Shuyi Xue, Yu Zhou, Jin Zhang, et al.
PubMed (2019) Vol. 11, Iss. 4, pp. 2580-2589
Closed Access | Times Cited: 52
Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases
Yun Seok Kim, Sang Geon Kim
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 715-727
Open Access | Times Cited: 45
Yun Seok Kim, Sang Geon Kim
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 715-727
Open Access | Times Cited: 45
A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma
Yongbiao Huang, Sheng Chen, Qin Wan, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 40
Yongbiao Huang, Sheng Chen, Qin Wan, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 40
The E2F1/USP11 positive feedback loop promotes hepatocellular carcinoma metastasis and inhibits autophagy by activating ERK/mTOR pathway
Lijun Qiao, Qiangnu Zhang, Zhe Sun, et al.
Cancer Letters (2021) Vol. 514, pp. 63-78
Closed Access | Times Cited: 39
Lijun Qiao, Qiangnu Zhang, Zhe Sun, et al.
Cancer Letters (2021) Vol. 514, pp. 63-78
Closed Access | Times Cited: 39
HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway
Junqi Wang, Kehu Yang, Xin Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1275-1287
Closed Access | Times Cited: 5
Junqi Wang, Kehu Yang, Xin Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1275-1287
Closed Access | Times Cited: 5
DKK1 promotes hepatocellular carcinoma inflammation, migration and invasion: Implication of TGF-β1
Maha Fezza, Mayssam Moussa, Rita Aoun, et al.
PLoS ONE (2019) Vol. 14, Iss. 9, pp. e0223252-e0223252
Open Access | Times Cited: 40
Maha Fezza, Mayssam Moussa, Rita Aoun, et al.
PLoS ONE (2019) Vol. 14, Iss. 9, pp. e0223252-e0223252
Open Access | Times Cited: 40
Role of Alpha-Fetoprotein in Hepatocellular Carcinoma Drug Resistance
Wei Li, Kun Liu, Yi Chen, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 6, pp. 1126-1142
Closed Access | Times Cited: 38
Wei Li, Kun Liu, Yi Chen, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 6, pp. 1126-1142
Closed Access | Times Cited: 38
Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways
Liang Yang, Yue Hu, Guanbao Zhou, et al.
Bioscience Reports (2020) Vol. 40, Iss. 7
Open Access | Times Cited: 36
Liang Yang, Yue Hu, Guanbao Zhou, et al.
Bioscience Reports (2020) Vol. 40, Iss. 7
Open Access | Times Cited: 36
Comprehensive clinicopathologic study of alpha fetoprotein‐expression in a large cohort of patients with hepatocellular carcinoma
Dirk A. Ridder, Arndt Weinmann, Mario Schindeldecker, et al.
International Journal of Cancer (2021) Vol. 150, Iss. 6, pp. 1053-1066
Open Access | Times Cited: 31
Dirk A. Ridder, Arndt Weinmann, Mario Schindeldecker, et al.
International Journal of Cancer (2021) Vol. 150, Iss. 6, pp. 1053-1066
Open Access | Times Cited: 31
E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer
Hui Li, Shufen Zhao, Liwei Shen, et al.
Aging (2021) Vol. 13, Iss. 10, pp. 13626-13643
Open Access | Times Cited: 28
Hui Li, Shufen Zhao, Liwei Shen, et al.
Aging (2021) Vol. 13, Iss. 10, pp. 13626-13643
Open Access | Times Cited: 28
miR-210 promotes hepatocellular carcinoma progression by modulating macrophage autophagy through PI3K/AKT/mTOR signaling
Shumin Bi, Yidan Zhang, Jia Zhou, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 662, pp. 47-57
Open Access | Times Cited: 13
Shumin Bi, Yidan Zhang, Jia Zhou, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 662, pp. 47-57
Open Access | Times Cited: 13